Insights

We’re only just smoothing the surface of consumer skincare product personalisation. The current trend for products to be curated, customised or even bespoke to some degree, is simply the start. 

This paper highlights macro and micro factors affecting oncology and proposes a partnership-driven framework to catalyze innovation for oncology-focused biopharma – as well as the role that select high-impact technologies will have on the on the entire value-chain of cancer research and care delivery. 

The next step in the fight against coronavirus looks set to be mass screening of whole cities and towns. Symon Cotton, Head of Life Sciences at Cambridge Consultants, believes that so-called multipool screening could make all the difference to the success of this approach during the current second wave of the virus.

Metered-dose inhalers account for 3.5% of the UK National Health Service’s carbon footprint and are tagged as a carbon hotspot. But there is no reason that sustainability has to come at the cost of clinical benefit. 

Symon Cotton explores the use of pooled testing techniques for deploying mass Covid testing.  

In September the UK government announced Operation Moonshot – to deliver the mass screening of 10 million samples for COVID-19 every day. Andrew Goulter takes a pragmatic look at five key areas of focus if we are to increase screening efficiency and capacity. 

Ryan Chaves explores some of the approaches currently being used – or considered – to address concerns over the cybersecurity of implanted medical devices.

“You mean you just want me to throw all that packaging away? There’s enough waste here to fill three trash cans!” The fact that we repeatedly get feedback like this during patient interviews these days highlights just how important the environmental impact of a product has become.

With fewer than 100 days of the Brexit transition period remaining, it’s clear that medical device manufacturers will need to respond efficiently to the new regulatory developments. Sara Dodd looks at the unfolding new regulatory landscape.

Despite intense media focus and impassioned societal debate, meaningful progress on climate change is a glacially slow business - this is particularly true in the medical device sector. Dan Cowen explores how radical technological innovation is the way forward.

Biometrics are becoming increasingly commonplace tools in User Access Control (UAC) systems. Fingerprint scanners are now present in even mid to entry-level smartphones – putting this technology firmly at, well, our fingertips.

James Hallinan's takeaway from SynBioBeta 2020: Synbio is growing up and getting ever more relevant to the everyday.